title: Inhibition of bortezomib-induced apoptosis by red blood cell uptake.
authors.forename: L M C
authors.initials: LM
authors.lastname: Wheat
authors.forename: S L
authors.initials: SL
authors.lastname: Kohlhaas
authors.forename: J
authors.initials: J
authors.lastname: Monbaliu
authors.forename: R
authors.initials: R
authors.lastname: De Coster
authors.forename: A
authors.initials: A
authors.lastname: Majid
authors.forename: R J
authors.initials: RJ
authors.lastname: Walewska
authors.forename: M J S
authors.initials: MJ
authors.lastname: Dyer
mesh_terms: D000970:Antineoplastic Agents / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D017209:Apoptosis / Q000187:drug effects*; D001897:Boronic Acids / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D000069286:Bortezomib; D004912:Erythrocytes / Q000378:metabolism*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy; D011719:Pyrazines / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib